[Congressional letterhead]
[Date]
The Honorable [Name] Comptroller General of the United States U.S. Government Accountability Office 441 G Street NW Washington, DC 20548
Attn: Office of the General Counsel, Appropriations Law
Dear Comptroller General [Name]:
I request a legal decision on whether [agency] violated the prohibition on the use of appropriated funds “for publicity or propaganda purposes within the United States not heretofore authorized by Congress,” Consolidated Appropriations Act, 2026, Pub. L. No. 119-75, div. E, §718, 140 Stat. 173, 495 [and the corresponding provision of the act in effect for the fiscal year in which the activity occurred], and, if so, whether [agency] also violated the Antideficiency Act.
Background. Congress has legislated repeatedly concerning unidentified anomalous phenomena (UAP), including by establishing the All-domain Anomaly Resolution Office, 50 U.S.C. §3373, by creating a protected channel for reporting UAP-related information, 50 U.S.C. §3373b, and by requiring the collection and review of UAP records, Pub. L. No. 118-31, §§1841-1843. Congress has not authorized any agency to conduct campaigns to shape public opinion about UAP or about individuals who report UAP information.
Facts. Records obtained by [source] indicate that [describe concisely, citing attached records]: 1. [e.g., “From [date] to [date], [agency] paid [contractor] $[__] under contract no. [__] to prepare articles and video segments concerning UAP that were distributed to [outlets] without attribution to the agency.”] 2. [e.g., “Agency personnel provided prepared text to [outlet] that was published as the outlet’s own reporting.”] 3. [e.g., “Agency communications characterized named witnesses as [__] in material distributed to the public.”]
Questions. Please address: 1. Whether the activities described were “publicity or propaganda” within the meaning of §718, in particular whether they constituted covert propaganda because the agency’s role was concealed from the intended audience. 2. Whether the activities were otherwise authorized by Congress. 3. Whether any obligation or expenditure for them violated the Antideficiency Act, and, if so, whether [agency] has reported the violation as 31 U.S.C. §1351 requires. 4. What appropriation was charged, and in what amounts.
I ask that GAO obtain [agency]’s views and the relevant contract, financial, and communications records, including any classified annex, and that GAO prepare an unclassified decision suitable for public release.
Please contact [staff name, phone, email] with questions.
Sincerely,
[Member of Congress]
Enclosures: [list]